Spravato®Registry-verifiedDesignated-centers model

Klinik Sonnenhalde

Riehen, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 61 645 46 46
  • Websitehttps://www.sonnenhalde.ch

About this provider

Sonnenhalde AG is a psychiatric and psychotherapeutic clinic in Riehen (canton Basel-Stadt) with 68 inpatient beds across three houses, plus a day clinic and outpatient consultations, and additional sites in Basel and Reinach. Per its own pages it helps with depression, burnout, anxiety disorders, eating disorders, borderline, substance dependence and mother-child treatment, combining psychotherapy (including third-wave CBT approaches such as ACT) with art, body, breathing, milieu and hydrotherapy. Its public pages do not describe a dedicated esketamine programme.

Services & programs

  • Inpatient psychiatric treatment (68 beds, Riehen)
  • Psychiatric-psychotherapeutic day clinic
  • Outpatient consultations (Sprechstunde)
  • Treatment focuses: depression, burnout, anxiety, eating disorders, borderline, substance dependence, mother-child treatment
  • Psychotherapy including cognitive-behavioural and ACT approaches
  • Art therapy, body therapy, breathing therapy, milieu therapy, hydrotherapy, therapeutic archery, theatre therapy
  • Social-psychiatric service and pastoral care

Common questions

Can Sonnenhalde help with insurance approval questions?

Yes. The reception (+41 61 645 46 46) explicitly answers questions on insurance, cost coverage and cost approvals (Kostengutsprachen); for esketamine the insurer's approval must be in place before the first dose per the BAG Limitatio.

Who qualifies for reimbursed Spravato treatment?

Adults aged 18-74 with treatment-resistant depression: at least two antidepressants with different mechanisms plus one augmentation attempt without sufficient response, and confirmed severity. Referral runs through your treating psychiatrist, and coverage is limited to a maximum of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers in Switzerland; see the country guide and the limited-medical-use PAT program.

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Klinik Sonnenhalde only with your explicit consent, and you can download it for yourself either way.

Why enquire via PsyAccess

  • Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
  • A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
  • Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.
Check my fit & enquire

About two minutes. The check itself runs in your browser: your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.